Lunai Bioworks announces 1-for-8 reverse stock split effective May 22, 2026

Lunai Bioworks Inc.

Reverse split ratio set at 1-for-8; stockholder approval obtained on May 8, 2026.
Shares outstanding will reduce from ~36.27M to ~4.53M; fractional shares rounded up.
Split aims to regain compliance with Nasdaq minimum bid price of $1.00 per share.
New CUSIP number 29350E302; trading symbol LNAI unchanged.
Previous 1-for-10 reverse split was effected on September 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.